Vitamin D may ease cancer treatment skin toxicity
Most patients reported symptom relief within 10 days, while 73% continued anticancer therapy without interruption.
-
By
-
Andrea Surnit
-
September 30, 2026
-
Clinical Scorecard: Vitamin D may ease cancer treatment skin toxicity
At a Glance
| Category | Detail |
|---|
| Condition | Chemotherapy- and radiation-associated skin toxicity |
| Key Mechanisms | High-dose oral vitamin D administration |
| Target Population | Patients undergoing chemotherapy or radiation therapy with skin toxic effects |
| Care Setting | Oncodermatology |
Key Highlights
- 87% of patients reported subjective symptom relief within 10 days
- Median time to improvement was 5 days overall
- No treatment-related adverse events were reported
- 73% of patients continued anticancer therapy without interruption
- Erythema scores decreased significantly from baseline
Guideline-Based Recommendations
Diagnosis
- Retrospective grading of erythema using a 5-point Likert scale
Management
- Consider high-dose oral vitamin D for skin toxic effects
Monitoring & Follow-up
- Monitor serum calcium levels and vitamin D levels post-treatment
Risks
- Potential for skin toxic effects leading to therapy discontinuation
Patient & Prescribing Data
33 patients with toxic erythema of chemotherapy or acute radiation dermatitis
1 or 2 doses of 100,000 IU of cholecalciferol or ergocalciferol administered
Clinical Best Practices
- Administer high-dose vitamin D early for severe inpatient presentations
- Consider concurrent supportive treatments such as topical corticosteroids
Related Resources & Content
